Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

Int J Hematol. 2019 Feb;109(2):241. doi: 10.1007/s12185-018-02564-z.

¹ Department of Pediatrics, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan. m2taki@marianna-u.ac.jp.
² Department of Laboratory Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
³ Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
⁴ Department of Pediatrics, Nara Medical University, Kashihara, Japan.
⁵ Japanese Red Cross Society Tokai-Hokuriku Block Blood Center, Seto, Japan.
⁶ Department of Medical Affairs, Shire, Tokyo, Japan.
⁷ Department of Clinical Scientific Writing, Shire, Tokyo, Japan.
⁸ Department of Biostatistics, Shire, Vienna, Austria.
⁹ Kitakyushu Yahatahigashi Hospital, Kitakyusyu, Japan.

Abstract

The authors would like to correct the errors in the publication of the original article. The correction details are given below.